Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Idiopathic Urticaria”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Not applicableUnknownNCT05992987
What this trial is testing

Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Sohag University 90
Not applicableStudy completedNCT06053801
What this trial is testing

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 55
Not applicableStudy completedNCT04583475
What this trial is testing

Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

Who this might be right for
Spontaneous Urticaria, Chronic
University Hospital, Lille 163
Post-approval studies (Phase 4)UnknownNCT06250400
What this trial is testing

Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria
Hangzhou Grand Biologic Pharmaceutical, Inc. 252
Large-scale testing (Phase 3)Study completedNCT01264939
What this trial is testing

A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists

Who this might be right for
Chronic Idiopathic Urticaria
Genentech, Inc. 336
Not applicableEnrolling By InvitationNCT07632040
What this trial is testing

Pseudoallergen-Free and Low-Histamine Diet in Adolescents With Chronic Spontaneous Urticaria

Who this might be right for
Pediatric Chronic Spontaneous Urticaria
Istanbul University 120
Testing effectiveness (Phase 2)Study completedNCT02649218
What this trial is testing

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 226
Early research (Phase 1)Study completedNCT05373355
What this trial is testing

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Who this might be right for
Chronic Spontaneous Urticaria
Hangzhou Highlightll Pharmaceutical Co., Ltd 41
Not applicableLooking for participantsNCT07833696
What this trial is testing

Characteristics and Management of Patients With Severe Chronic Spontaneous and/or Inducible Urticaria Refractory to Optimized Omalizumab Treatment: A French Multicenter Observational Study.

Who this might be right for
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Centre Hospitalier Universitaire de Besancon 73
Testing effectiveness (Phase 2)Study completedNCT03437278
What this trial is testing

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 49
Early research (Phase 1)Ended earlyNCT04513548
What this trial is testing

Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria

Who this might be right for
Chronic Spontaneous UrticariaCholinergic UrticariaCold Urticaria
Novartis Pharmaceuticals 11
Early research (Phase 1)Study completedNCT05960708
What this trial is testing

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

Who this might be right for
Allergic DiseaseChronic Spontaneous UrticariaChronic Inducible Urticaria+1 more
Yuhan Corporation 30
Testing effectiveness (Phase 2)WithdrawnNCT05129423
What this trial is testing

MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Genentech, Inc.
Post-approval studies (Phase 4)Study completedNCT00795522
What this trial is testing

An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)

Who this might be right for
Urticaria
Organon and Co 51
Testing effectiveness (Phase 2)Looking for participantsNCT07717905
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria
Bambusa Therapeutics 48
Not applicableStudy completedNCT04314999
What this trial is testing

Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous UrticariaParasitic Disease
University Hospital, Basel, Switzerland 57
Not applicableStudy completedNCT01637116
What this trial is testing

Profiling Urticaria for the Identification of Subtypes

Who this might be right for
Non-autoreactive Chronic Spontaneous UrticariaAutoimmune Chronic Spontaneous UrticariaAutoreactive, Non-autoimmune Chronic Spontaneous Urticaria
Marcus Maurer 195
Post-approval studies (Phase 4)Study completedNCT00264303
What this trial is testing

CUTE (Chronic Urticaria Treatment Evaluation)

Who this might be right for
Chronic Idiopathic Urticaria
UCB Pharma 886
Large-scale testing (Phase 3)Study completedNCT01960283
What this trial is testing

Methotrexate in the Treatment of Chronic Idiopathic Urticaria

Who this might be right for
Chronic Urticaria
University Hospital, Tours 83
Large-scale testing (Phase 3)Study completedNCT01723072
What this trial is testing

Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy

Who this might be right for
Chronic Spontaneous UrticariaAngioedema
Novartis Pharmaceuticals 91
Next Page